Related references
Note: Only part of the references are listed.Salivary alpha-synuclein (total and oligomeric form): potential biomarkers in Parkinson's disease
Hala Shaheen et al.
EGYPTIAN JOURNAL OF NEUROLOGY PSYCHIATRY AND NEUROSURGERY (2020)
Respiratory Failure in Amyotrophic Lateral Sclerosis
Shannon Niedermeyer et al.
CHEST (2019)
α-Synuclein in salivary extracellular vesicles as a potential biomarker of Parkinson's disease
Zhentang Cao et al.
NEUROSCIENCE LETTERS (2019)
Salivary alpha-synuclein in the diagnosis of Parkinson's disease and Progressive Supranuclear Palsy
Giorgio Vivacqua et al.
PARKINSONISM & RELATED DISORDERS (2019)
Mesenchymal Stem Cells: A Potential Therapeutic Approach for Amyotrophic Lateral Sclerosis?
Agnese Gugliandolo et al.
STEM CELLS INTERNATIONAL (2019)
Levels of cortisol and neurotrophic factor brain-derived in Parkinson's disease
Camila Medeiros Costa et al.
NEUROSCIENCE LETTERS (2019)
Salivary alpha-synuclein as a biomarker for Parkinson's disease: a systematic review
Anastasia Bougea et al.
JOURNAL OF NEURAL TRANSMISSION (2019)
Alzheimer's disease
C. A. Lane et al.
EUROPEAN JOURNAL OF NEUROLOGY (2018)
Evaluation of salivary heme oxygenase-1 as a potential biomarker of early Parkinson's disease
Wei Song et al.
MOVEMENT DISORDERS (2018)
No association of salivary total tau concentration with Alzheimer's disease
Nicholas J. Ashton et al.
NEUROBIOLOGY OF AGING (2018)
Salivary biomarkers for the diagnosis and monitoring of neurological diseases
Raymond Farah et al.
BIOMEDICAL JOURNAL (2018)
Salivary beta amyloid protein levels are detectable and differentiate patients with Alzheimer's disease dementia from normal controls: preliminary findings
Marwan N. Sabbagh et al.
BMC NEUROLOGY (2018)
Top-down proteomic profiling of human saliva in multiple sclerosis patients
Barbara Manconi et al.
JOURNAL OF PROTEOMICS (2018)
A multicentric pharmacovigilance study: collection and analysis of adverse drug reactions in relapsing-remitting multiple sclerosis patients
Agnese Gugliandolo et al.
THERAPEUTICS AND CLINICAL RISK MANAGEMENT (2018)
Immunoglobulin free light chains in saliva: a potential marker for disease activity in multiple sclerosis
B. Kaplan et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2018)
A Method for Diagnosing Alzheimer's Disease Based on Salivary Amyloid-β Protein 42 Levels
Moonhee Lee et al.
JOURNAL OF ALZHEIMERS DISEASE (2017)
Association of BDNF Val66MET Polymorphism With Parkinson's Disease and Depression and Anxiety Symptoms
Fernanda Carvalho Cagni et al.
JOURNAL OF NEUROPSYCHIATRY AND CLINICAL NEUROSCIENCES (2017)
Not just amyloid: physiological functions of the amyloid precursor protein family
Ulrike C. Mueller et al.
NATURE REVIEWS NEUROSCIENCE (2017)
Current view and perspectives in amyotrophic lateral sclerosis
Stephane Mathis et al.
NEURAL REGENERATION RESEARCH (2017)
Amyotrophic lateral sclerosis
Orla Hardiman et al.
Nature Reviews Disease Primers (2017)
Parkinson's disease psychosis: presentation, diagnosis and management
Ruth B. Schneider et al.
NEURODEGENERATIVE DISEASE MANAGEMENT (2017)
ALS: A bucket of genes, environment, metabolism and unknown ingredients
Monica Zufiria et al.
PROGRESS IN NEUROBIOLOGY (2016)
Abnormal Salivary Total and Oligomeric Alpha-Synuclein in Parkinson's Disease
Giorgio Vivacqua et al.
PLOS ONE (2016)
Markers of oxidative stress in plasma and saliva in patients with multiple sclerosis
Martin Karlik et al.
CLINICAL BIOCHEMISTRY (2015)
Elevated salivary protein in Parkinson's disease and salivary DJ-1 as a potential marker of disease severity
Joseph M. Masters et al.
PARKINSONISM & RELATED DISORDERS (2015)
Non-Invasive Screening for Alzheimer's Disease by Sensing Salivary Sugar Using Drosophila Cells Expressing Gustatory Receptor (Gr5a) Immobilized on an Extended Gate Ion-Sensitive Field-Effect Transistor (EG-ISFET) Biosensor
Hui-Chong Lau et al.
PLOS ONE (2015)
Astrocyte Overexpression of Heme Oxygenase-1 Improves Outcome After Intracerebral Hemorrhage
Jing Chen-Roetling et al.
STROKE (2015)
Clinical and diagnostic utility of saliva as a non-invasive diagnostic fluid: a systematic review
Lazaro Alessandro Soares Nunes et al.
BIOCHEMIA MEDICA (2015)
Immunology of Relapse and Remission in Multiple Sclerosis
Lawrence Steinman
ANNUAL REVIEW OF IMMUNOLOGY, VOL 32 (2014)
Antibody-based magnetic nanoparticle immunoassay for quantification of Alzheimer's disease pathogenic factor
Chang-Beom Kim et al.
JOURNAL OF BIOMEDICAL OPTICS (2014)
Cheek cell-derived α-synuclein and DJ-1 do not differentiate Parkinson's disease from control
Tessandra Stewart et al.
NEUROBIOLOGY OF AGING (2014)
Salivary DJ-1 could be an indicator of Parkinson's disease progression
Wen-Yan Kang et al.
FRONTIERS IN AGING NEUROSCIENCE (2014)
Saliva α-Synuclein and A High Extinction Coefficient Protein: A Novel Approach in Assessment Biomarkers of Parkinson's Disease
Marwan S. M. Al-Nimer et al.
NORTH AMERICAN JOURNAL OF MEDICAL SCIENCES (2014)
Amyloid-β Positron Emission Tomography Imaging Probes: A Critical Review
Vladimir Kepe et al.
JOURNAL OF ALZHEIMERS DISEASE (2013)
Free light chain monomer-dimer patterns in the diagnosis of multiple sclerosis
Batia Kaplan et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2013)
Gene-environment interactions in Parkinson's disease: Specific evidence in humans and mammalian models
Jason R. Cannon et al.
NEUROBIOLOGY OF DISEASE (2013)
Peripheral oxidative stress in relapsing-remitting multiple sclerosis
Inmaculada Tasset et al.
CLINICAL BIOCHEMISTRY (2012)
Proteolytic processing of Alzheimer's ss-amyloid precursor protein
Han Zhang et al.
JOURNAL OF NEUROCHEMISTRY (2012)
The role of antigen presenting cells in multiple sclerosis
Emily M. L. Chastain et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2011)
Radical changes in multiple sclerosis pathogenesis
Jack van Horssen et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2011)
Salivary α-synuclein and DJ-1: potential biomarkers for Parkinson's disease
Ivana Devic et al.
BRAIN (2011)
Diagnostic Potential of Saliva: Current State and Future Applications
Tina Pfaffe et al.
CLINICAL CHEMISTRY (2011)
Phosphorylated α-synuclein can be detected in blood plasma and is potentially a useful biomarker for Parkinson's disease
Penelope G. Foulds et al.
FASEB JOURNAL (2011)
Salivary Tau Species are Potential Biomarkers of Alzheimer's Disease
Min Shi et al.
JOURNAL OF ALZHEIMERS DISEASE (2011)
Salivary cortisol levels in Parkinson's disease and its correlation to risk behaviour
Atbin Djamshidian et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2011)
α-Synuclein and tau concentrations in cerebrospinal fluid of patients presenting with parkinsonism: a cohort study (vol 10, pg 230, 2011)
B. Mollenhauer et al.
LANCET NEUROLOGY (2011)
APP processing in Alzheimer's disease
Yun-Wu Zhang et al.
MOLECULAR BRAIN (2011)
α-Synuclein and tau concentrations in cerebrospinal fluid of patients presenting with parkinsonism: a cohort study
Brit Mollenhauer et al.
LANCET NEUROLOGY (2011)
Serum heme oxygenase-1 levels are increased in Parkinson's disease but not in Alzheimer's disease
I. Mateo et al.
ACTA NEUROLOGICA SCANDINAVICA (2010)
Saliva levels of Abeta1-42 as potential biomarker of Alzheimer's disease: a pilot study
Felix Bermejo-Pareja et al.
BMC NEUROLOGY (2010)
Free light chain monomers in the diagnosis of multiple sclerosis
Batia Kaplan et al.
JOURNAL OF NEUROIMMUNOLOGY (2010)
Serum levels of brain-derived neurotrophic factor correlate with motor impairment in Parkinson's disease
Paula Scalzo et al.
JOURNAL OF NEUROLOGY (2010)
The clinical use of structural MRI in Alzheimer disease
Giovanni B. Frisoni et al.
NATURE REVIEWS NEUROLOGY (2010)
The antimicrobial peptides derived from chromogranin/secretogranin family, new actors of innate immunity
Peiman Shooshtarizadeh et al.
REGULATORY PEPTIDES (2010)
Soluble HLA class I and class II antigens in patients with multiple sclerosis
M. Ott et al.
TISSUE ANTIGENS (2010)
Oxidative stress is increased in serum from Mexican patients with relapsing-remitting multiple sclerosis
Genaro Gabriel Ortiz et al.
DISEASE MARKERS (2009)
CSF oligoclonal band status informs prognosis in multiple sclerosis: a case control study of 100 patients
F. G. Joseph et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2009)
Chromogranin peptides in amyotrophic lateral sclerosis
A. Schrott-Fischer et al.
REGULATORY PEPTIDES (2009)
Diagnosing Parkinson's disease: The patient perspective
Teneille E. Gofton et al.
CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES (2008)
Salivary Chromogranin A: Useful and Quantitative Biochemical Marker of Affective State in Patients with Amyotrophic Lateral Sclerosis
Konen Obayashi et al.
INTERNAL MEDICINE (2008)
Elevated levels of kappa free light chains in CSF support the diagnosis of multiple sclerosis
Stefan Presslauer et al.
JOURNAL OF NEUROLOGY (2008)
Neurodegeneration in multiple sclerosis: The role of oxidative stress and excitotoxicity
R. E. Gonsette
JOURNAL OF THE NEUROLOGICAL SCIENCES (2008)
Differential diagnosis of suspected multiple sclerosis: a consensus approach
D. H. Miller et al.
MULTIPLE SCLEROSIS JOURNAL (2008)
Red blood cells are the major source of alpha-synuclein in blood
Robin Barbour et al.
NEURODEGENERATIVE DISEASES (2008)
Protein-protein interactions in the assembly and subcellular trafficking of the BACE (β-site amyloid precursor protein-cleaving enzyme) complex of Alzheimer's disease
R. B. Parsons et al.
BIOCHEMICAL SOCIETY TRANSACTIONS (2007)
Human saliva proteome analysis and disease biomarker discovery
Shen Hu et al.
EXPERT REVIEW OF PROTEOMICS (2007)
Saliva specimen: A new laboratory tool for diagnostic and basic investigation
Silvia Chiappin et al.
CLINICA CHIMICA ACTA (2007)
Saliva soluble HLA as a potential marker of response to interferon-β1a in multiple sclerosis:: A preliminary study
Alireza Minagar et al.
JOURNAL OF NEUROINFLAMMATION (2007)
Quantitative study of salivary secretion in Parkinson's disease
Omar R. Tumilasci et al.
MOVEMENT DISORDERS (2006)
Medical progress: Multiple sclerosis - The plaque and its pathogenesis
EM Frohman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Chromogranin-mediated secretion of mutant superoxide dismutase proteins linked to amyotrophic lateral sclerosis
M Urushitani et al.
NATURE NEUROSCIENCE (2006)
Soluble HLA measurement in saliva and cerebrospinal fluid in Caucasian patients with multiple sclerosis: a preliminary study
Irena Adamashvili et al.
JOURNAL OF NEUROINFLAMMATION (2005)
Tau pathology in Alzheimer disease and other tauopathies
K Iqbal et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2005)
Correlation between elevated levels of amyloid β-peptide in the brain and cognitive decline
J Näslund et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2000)
Share Paper
